129 related articles for article (PubMed ID: 2953168)
1. Yersinia arthritis, immune functions and histocompatibility antigens.
Repo H; Leirisalo-Repo M; Gripenberg M; Koskimies S; Kontiainen S; Laitinen O
Acta Pathol Microbiol Immunol Scand C; 1986 Dec; 94(6):245-52. PubMed ID: 2953168
[TBL] [Abstract][Full Text] [Related]
2. Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro.
Leirisalo M; Repo H; Tiilikainen A; Kosunen TU; Laitinen O
Arthritis Rheum; 1980 Sep; 23(9):1036-44. PubMed ID: 7417352
[TBL] [Abstract][Full Text] [Related]
3. Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera.
Repo H; Leirisalo M; Tiilikainen A; Laitinen O
Arthritis Rheum; 1982 Jun; 25(6):655-61. PubMed ID: 6980007
[TBL] [Abstract][Full Text] [Related]
4. Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations.
Repo H; Koivuranta-Vaara P; Leirisalo-Repo M
Ann Rheum Dis; 1988 Jun; 47(6):452-7. PubMed ID: 2838004
[TBL] [Abstract][Full Text] [Related]
5. Enhanced neutrophil migration in vivo HLA B27 positive subjects.
Koivuranta-Vaara P; Repo H; Leirisalo M; Kiistala U; Osterman T; Vapaatalo H
Ann Rheum Dis; 1984 Apr; 43(2):181-5. PubMed ID: 6370148
[TBL] [Abstract][Full Text] [Related]
6. Antibody producing capacity to the bacteriophage phi X174 in yersinia arthritis.
Bucknall R; Leirisalo-Repo M; Laitinen O; Jones JV
Ann Rheum Dis; 1987 Dec; 46(12):883-8. PubMed ID: 2962540
[TBL] [Abstract][Full Text] [Related]
7. Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.
Repo H; Jäättelä M; Leirisalo-Repo M; Hurme M
Clin Exp Immunol; 1988 Jun; 72(3):410-4. PubMed ID: 3262459
[TBL] [Abstract][Full Text] [Related]
8. Immune responses in yersinia-associated reactive arthritis.
Aho K; Ahvonen P; Juvakoski T; Kousa M; Leirisalo M; Laitinen O
Ann Rheum Dis; 1979; 38 Suppl 1(Suppl 1):suppl 123-6. PubMed ID: 318096
[No Abstract] [Full Text] [Related]
9. Immune function in patients with previous yersinia arthritis: lymphocyte responses to PHA and Staphylococcus aureus strain Cowan I.
Repo H; Leirisalo-Repo M
Acta Pathol Microbiol Immunol Scand C; 1986 Feb; 94(1):39-43. PubMed ID: 3487200
[TBL] [Abstract][Full Text] [Related]
10. Yersinia antibodies in inflammatory joint diseases.
Granfors K; Isomäki H; von Essen R; Maatela J; Kalliomäki JL; Toivanen A
Clin Exp Rheumatol; 1983; 1(3):215-8. PubMed ID: 6335856
[TBL] [Abstract][Full Text] [Related]
11. IgM, IgG, and IgA synthesis in vitro in persons suffering from yersinia arthritis and in patients with ankylosing spondylitis.
Vuento R; Eskola J; Leino R; Koskimies S; Viander M
Ann Rheum Dis; 1984 Apr; 43(2):186-91. PubMed ID: 6370149
[TBL] [Abstract][Full Text] [Related]
12. Yersinia arthritis: a clinical, immunological, and family study of 2 cases.
Sheldon PJ; Mair NS; Fox E
Ann Rheum Dis; 1982 Apr; 41(2):153-8. PubMed ID: 6978685
[TBL] [Abstract][Full Text] [Related]
13. HLA phenotypes in patients with rheumatic fever, rheumatic heart disease, and Yersinia arthritis.
Leirisalo M; Laitinen O; Tiilikainen A
J Rheumatol Suppl; 1977; 3():78-83. PubMed ID: 266605
[TBL] [Abstract][Full Text] [Related]
14. Effects of HLA-B27 positive and negative sera on migration of polymorphonuclear leukocytes in vitro.
Repo H; Leirisalo-Repo M; Koskimies S
Clin Exp Rheumatol; 1988; 6(3):227-31. PubMed ID: 3263238
[TBL] [Abstract][Full Text] [Related]
15. Inflammation in Yersinia arthritis.
Repo H; Meri S; Leirisalo-Repo M
Contrib Microbiol Immunol; 1987; 9():141-4. PubMed ID: 3499289
[No Abstract] [Full Text] [Related]
16. Pathogenesis of Yersinia-triggered reactive arthritis: immunological, microbiological and clinical aspects.
Toivanen A; Granfors K; Lahesmaa-Rantala R; Leino R; Ståhlberg T; Vuento R
Immunol Rev; 1985 Aug; 86():47-70. PubMed ID: 3930389
[TBL] [Abstract][Full Text] [Related]
17. Complement activation and HLA-B27.
Meri S; Partanen J; Leirisalo-Repo M; Repo H
Ann Rheum Dis; 1988 Mar; 47(3):210-4. PubMed ID: 3258504
[TBL] [Abstract][Full Text] [Related]
18. Relation between HLA-B27 and clinical features in patients with yersinia arthritis.
Laitinen O; Leirisalo M; Skylv G
Arthritis Rheum; 1977 Jun; 20(5):1121-4. PubMed ID: 869958
[TBL] [Abstract][Full Text] [Related]
19. Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation.
Chu E; Umetsu D; Rosen F; Geha RS
J Clin Invest; 1983 Sep; 72(3):1124-9. PubMed ID: 6193142
[TBL] [Abstract][Full Text] [Related]
20. Depressed lymphocyte transformation by yersinia and Escherichia coli in yersinia arthritis.
Leino R; Vuento R; Koskimies S; Viander M; Toivanen A
Ann Rheum Dis; 1983 Apr; 42(2):176-81. PubMed ID: 6342552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
